{"title":"Pseudouridine and N1-methylpseudouridine as potent nucleotide analogues for RNA therapy and vaccine development","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/CB/D4CB00022F","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4CB00022F\" /></p></div><div><i><b>RSC Chem. Biol.</b></i>, 2024, Advance Article<br /><b>DOI</b>: 10.1039/D4CB00022F, Review Article</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Lyana L. Y. Ho, Gabriel H. A. Schiess, Pâmella Miranda, Gerald Weber, Kira Astakhova<br /><em>N</em>1-Methylpseudouridine, and its “parent” analogue pseudouridine, are potent nucleotide analogues for RNA therapy and vaccine development.<br />To cite this article before page numbers are assigned, use the DOI form of citation above.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Chem. Biol. latest articles","siteHash":"1843dfbfc0bf39b0fe9743f763f2ba4e6cb90d9c3732ca303b2e6e5daeb3deb0","entryHash":"db1a509c6ff4aa62063f35b03b55dc95457df83130c9470ce4d73c13002be66d","category":"Environment"}